apo-866
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2006 (NCT00432107)
Timeline
Indications
Mechanism of action
NAMPT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- apo866
- apo866
- apo866
- apo 866
- apo-866
- fk 866
- fk-866
- fk866 cpd
- n-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00431912 | Phase 2 | Feb 1, 2007 | Valerio |
| NCT00435084 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2007 | Valerio |
| NCT00432107 | Phase 2 | Jul 1, 2006 | Valerio |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Valerio | For profit | 3 | 3 | 1 | 2006 |
1 organizations
Page 1 / 1